Ausgabe 6/2018
Inhalt (9 Artikel)
The emerging role of lncRNAs in the regulation of cancer stem cells
Rosario Castro-Oropeza, Jorge Melendez-Zajgla, Vilma Maldonado, Karla Vazquez-Santillan
Emerging ways to treat breast cancer: will promises be met?
Pouria Samadi, Sahar Saki, Fatemeh Karimi Dermani, Mona Pourjafar, Massoud Saidijam
Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones
Lisett Contreras, Ruben I. Calderon, Armando Varela-Ramirez, Hong-Yu Zhang, Yuan Quan, Umashankar Das, Jonathan R. Dimmock, Rachid Skouta, Renato J. Aguilera
Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma
Xuan Sun, Robert C. G. Martin, Qianqian Zheng, Russell Farmer, Harshul Pandit, Xuanyi Li, Kevin Jacob, Jian Suo, Yan Li
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells
Eun-Hui Jeong, Tae-Gul Lee, Yun Jung Ko, Seo Yun Kim, Hye-Ryoun Kim, Hyunggee Kim, Cheol Hyeon Kim
In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells
Claudia Busonero, Stefano Leone, Fabrizio Bianchi, Filippo Acconcia
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report
Alessandro Del Gobbo, Nicola Fusco, Marco Barella, Giulia Ercoli, Amedeo Sciarra, Alessandro Palleschi, Fabio Pagni, Caterina Marchiò, Mauro Papotti, Stefano Ferrero
Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report
Rajesh C. Rao, May P. Chan, Chris A. Andrews, Alon Kahana